PHYSICIAN'S SEAL LLC – Trademark Portfolio
Entity Type: 16
PHYSICIAN'S SEAL LLC holds 67 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 66 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include REMFRESH, ULTRAMEL, SLEEP BETTER. LIVE BETTER., and CONTINUOUS RELEASE AND ABSORPTION MELATONIN. The owner is based in BOCA RATON, FL.
1100 Holland Drive
BOCA RATON, FL 33487
Showing of trademarks Trademarks
Trademark Classifications
PHYSICIAN'S SEAL LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does PHYSICIAN'S SEAL LLC have?
PHYSICIAN'S SEAL LLC has 67 U.S. trademarks filed with the USPTO. Of these, 4 registered, 36 abandoned, 27 cancelled.
What trademark classes does PHYSICIAN'S SEAL LLC file in?
PHYSICIAN'S SEAL LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PHYSICIAN'S SEAL LLC's most well-known trademarks?
PHYSICIAN'S SEAL LLC's registered trademark portfolio includes well-known marks such as REMFRESH, ULTRAMEL, SLEEP BETTER. LIVE BETTER., and CONTINUOUS RELEASE AND ABSORPTION MELATONIN. These are among 4 currently registered trademarks in the portfolio.
What is PHYSICIAN'S SEAL LLC's trademark registration success rate?
PHYSICIAN'S SEAL LLC has a 6% trademark registration rate, with 4 out of 67 resolved applications resulting in successful registration. Currently, 0 applications are pending review.